Targeted Melanoma Therapy Advancing in BRAF Positive Cases 2026

hat ein neuen Blog hinzugefügt Health

2025-12-17 07:11:59 -

Overcoming Resistance Mechanisms with Novel Kinase Inhibitors The discovery of the BRAF V600 mutation, present in approximately 50% of cutaneous cases, heralded the age of Targeted Melanoma Therapy. While initial responses to single-agent kinase inhibitors were often dramatic, resistance mechanisms invariably emerged, limiting progression-free survival. Current research is heavily focused on...

0 Kommentare 0 Geteilt 4 Ansichten 0 Bewertungen